{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:11:11Z","timestamp":1779376271426,"version":"3.53.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.arbres.2012.04.001","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T18:51:12Z","timestamp":1339613472000},"page":"247-257","source":"Crossref","is-referenced-by-count":187,"title":["Gu\u00eda Espa\u00f1ola de la EPOC (GesEPOC). Tratamiento farmacol\u00f3gico de la EPOC estable"],"prefix":"10.1016","volume":"48","author":[{"given":"Marc","family":"Miravitlles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Soler-Catalu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Almagro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Quintano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Riesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Trigueros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Pi\u00f1era","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"L\u00f3pez-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ancochea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2012.04.001_bib0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1183\/09031936.06.00024505","article-title":"Epidemiology and costs of chronic obstructive pulmonary disease","volume":"27","author":"Chapman","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.arbres.2011.10.007","article-title":"Clinical phenotypes of COPD. Identification, definition and implications for guidelines","volume":"48","author":"Miravitlles","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0015","series-title":"Plan de Calidad para el Sistema Nacional de Salud","year":"2009"},{"key":"10.1016\/j.arbres.2012.04.001_bib0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arbres.2011.05.008","article-title":"Hacia un nuevo enfoque en el tratamiento de la EPOC. La Gu\u00eda Espa\u00f1ola de la EPOC (GESEPOC)","volume":"47","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1157\/13119943","article-title":"Gu\u00eda Cl\u00ednica SEPAR-ALAT de diagn\u00f3stico y tratamiento de la EPOC","volume":"44","author":"Peces-Barba","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0030","year":"2010","journal-title":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR) y Sociedad Espa\u00f1ola de Medicina de Familia (semFYC)"},{"key":"10.1016\/j.arbres.2012.04.001_bib0035","unstructured":"Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. [consultado 13 Mar 2012] Disponible en: http:\/\/www.goldcopd.org."},{"key":"10.1016\/j.arbres.2012.04.001_bib0040","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease phenotypes. The future of COPD","volume":"182","author":"Han","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0045","first-page":"7","article-title":"Phenotypes of chronic obstructive pulmonary disease","volume":"5","author":"Pistolesi","year":"2010","journal-title":"Hot Topics Respir Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.arbres.2010.06.003","article-title":"Estrategias de tratamiento en la enfermedad pulmonar obstructiva cr\u00f3nica: una propuesta de sistematizaci\u00f3n","volume":"46","author":"Lopez-Campos","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/COPD.S2999","article-title":"Targeted treatment in COPD: a multi-system approach for a multi-system disease","volume":"4","author":"Anderson","year":"2009","journal-title":"Int J Chron Obst Pulm Dis"},{"issue":"Suppl 5","key":"10.1016\/j.arbres.2012.04.001_bib0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0300-2896(09)72952-7","article-title":"Tratamiento individualizado de la EPOC: una propuesta de cambio","volume":"45","author":"Miravitlles","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0065","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0070","first-page":"7","article-title":"The frequent exacerbator. A new phenotype in COPD?","volume":"6","author":"Soler Catalu\u00f1a","year":"2011","journal-title":"Hot Topics Respir Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1183\/09031936.00035909","article-title":"Predictive accuracy of patient-reported exacerbation frequency in COPD","volume":"37","author":"Quint","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/thx.2008.108027","article-title":"The overlap syndrome of asthma and COPD: what are its features and how important is it?","volume":"64","author":"Gibson","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.04.001_bib0085","first-page":"15","article-title":"The overlap syndrome between asthma and COPD: implications for management","volume":"16","author":"Miravitlles","year":"2011","journal-title":"Hot Topics Respir Med"},{"issue":"Suppl B","key":"10.1016\/j.arbres.2012.04.001_bib0090","doi-asserted-by":"crossref","first-page":"5B","DOI":"10.1155\/2007\/830570","article-title":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease \u2013 2007 update","volume":"14","author":"O\u2019Donnell","year":"2007","journal-title":"Can Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0095","series-title":"Guidelines for the diagnosis and treatment of COPD","author":"Nagai","year":"2009"},{"key":"10.1016\/j.arbres.2012.04.001_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.arbres.2011.12.009","article-title":"Documento de consenso sobre el fenotipo mixto EPOC-asma en la EPOC","author":"Soler-Catalu\u00f1a","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1148\/radiol.11110173","article-title":"Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes","volume":"261","author":"Han","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.arbres.2012.04.001_bib0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1164\/rccm.201106-0992OC","article-title":"Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease","volume":"185","author":"Nishimura","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0115","first-page":"762","article-title":"Chronic bronchitis, asthma, and pulmonary emphysema, a statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases","volume":"85","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.arbres.2012.04.001_bib0120","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1183\/09031936.95.08081333","article-title":"Chronic mucus hypersecretion in COPD and death from pulmonary infection","volume":"8","author":"Prescott","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0125","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.rmed.2011.02.003","article-title":"Cough and sputum production as risk factors for poor outcomes in patients with COPD","volume":"105","author":"Miravitlles","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0130","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00141611","article-title":"Chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study","author":"Montes de Oca","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0135","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1378\/chest.10-2948","article-title":"The chronic bronchitic phenotype of COPD. An analysis of the COPDGene study","volume":"140","author":"Kim","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.04.001_bib0140","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.200305-648OC","article-title":"Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease","volume":"70","author":"Patel","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1378\/chest.10-1758","article-title":"Factors associated with bronchiectasis in chronic obstructive pulmonary disease patients","volume":"140","author":"Mart\u00ednez-Garcia","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.04.001_bib0150","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0155","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.rmed.2008.12.005","article-title":"Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients","volume":"103","author":"Soler-Catalu\u00f1a","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0160","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.04.001_bib0165","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1378\/chest.121.5.1434","article-title":"Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD","volume":"121","author":"Nishimura","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.04.001_bib0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1183\/09031936.00021409","article-title":"Impact of changes in physical activity on health-related quality of life among patients with COPD","volume":"36","author":"Esteban","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0175","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/rccm.200607-896OC","article-title":"Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease","volume":"175","author":"Garc\u00eda-Aymerich","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1183\/09031936.00024608","article-title":"Physical activity in patients with COPD","volume":"33","author":"Watz","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/thx.2010.152876","article-title":"Lung function impairment. COPD hospitalisations and subsequent mortality","volume":"66","author":"Garc\u00eda-Aymerich","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.04.001_bib0190","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD Assessment Test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1183\/09031936.00177210","article-title":"Properties of the COPD assessment test in a cross-sectional European study","volume":"38","author":"Jones","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4104\/pcrj.2011.00041","article-title":"A new perspective on optimal care for patients with COPD","volume":"20","author":"Postma","year":"2011","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0205","first-page":"CD001387","article-title":"Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease","volume":"2","author":"Appleton","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbres.2012.04.001_bib0210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1465-9921-7-147","article-title":"Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo\/usual therapy: results of a meta-analysis","volume":"7","author":"Stockley","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2012.04.001_bib0215","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1183\/09031936.02.00240902","article-title":"Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial","volume":"19","author":"Aalbers","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0220","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0225","first-page":"237","article-title":"Long-acting \u03b2-adrenoceptor agonists in the management of COPD: focus on indacaterol","volume":"6","author":"Beier","year":"2011","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2012.04.001_bib0230","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thorax.58.5.399","article-title":"Health outcomes following six months treatment with once daily tiotropium compared to twice daily salmeterol in patients with COPD","volume":"58","author":"Brusasco","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.04.001_bib0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1741-7015-7-2","article-title":"Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis","volume":"7","author":"Puhan","year":"2009","journal-title":"BMC Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0240","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-147-9-200711060-00009","article-title":"Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline","volume":"147","author":"Wilt","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0245","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1008378","article-title":"Tiotropium versus salmeterol for the prevention of exacerbations of COPD","volume":"364","author":"Vogelmeier","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0250","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1183\/09031936.05.00140404","article-title":"Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD","volume":"26","author":"Van Noord","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0255","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/thx.2010.139113","article-title":"QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease","volume":"65","author":"Van Noord","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.04.001_bib0260","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1440-1843.2006.00897.x","article-title":"Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year","volume":"11","author":"Zhou","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.arbres.2012.04.001_bib0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2004.10.009","article-title":"Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"99","author":"Ram","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0270","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/rccm.168.7.818","article-title":"European Respiratory Society Statement: standards for the diagnosis and management of individuals with alpha-1-antitrypsin deficiency","volume":"168","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0275","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1157\/13095974","article-title":"Guidelines for the diagnosis and management of alpha-1-antitrypsin deficiency","volume":"42","author":"Vidal","year":"2006","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0280","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1465-9921-12-127","article-title":"The clinical features of overlap between COPD and asthma","volume":"12","author":"Hardin","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2012.04.001_bib0285","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1164\/ajrccm.162.5.9910112","article-title":"Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease","volume":"162","author":"Papi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0290","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0295","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.arbres.2011.01.016","article-title":"Arguments in favor of inhaled corticosteroids in COPD by phenotype instead of by severity","volume":"47","author":"Miravitlles","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1164\/rccm.200904-0492OC","article-title":"Efficacy and tolerability of budesonide\/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease","volume":"180","author":"Welte","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0305","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0310","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0315","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1164\/rccm.200602-244OC","article-title":"Impact of salmeterol\/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease","volume":"175","author":"Kardos","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0320","first-page":"CD006829","article-title":"Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease","volume":"4","author":"Nannini","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbres.2012.04.001_bib0325","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-146-8-200704170-00152","article-title":"Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial","volume":"146","author":"Aaron","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1164\/rccm.200610-1563OC","article-title":"Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease","volume":"176","author":"Calverley","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1465-9921-12-18","article-title":"Reduction of exacerbations by the PDE4 inhibitor roflumilast \u2014 the importance of defining different subsets of patients with COPD","volume":"12","author":"Rennard","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2012.04.001_bib0340","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(09)61252-6","article-title":"Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with long acting bronchodilators: two randomised clinical trials","volume":"374","author":"Fabbri","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2012.04.001_bib0345","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1183\/09031936.00178710","article-title":"Roflumilast with long-acting b2-agonists for COPD: influence of exacerbation history","volume":"38","author":"Bateman","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0350","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(00)88479-9","article-title":"Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a metaanalysis of published double-blind, placebo-controlled clinical trials","volume":"22","author":"Grandjean","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.arbres.2012.04.001_bib0355","first-page":"CD001287","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","volume":"3","author":"Poole","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbres.2012.04.001_bib0360","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(08)60869-7","article-title":"Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomized placebo-controlled study","volume":"371","author":"Zheng","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2012.04.001_bib0365","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study. BRONCUS): a randomized placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2012.04.001_bib0370","unstructured":"Staykova T, Black PN, Chacko EE, Poole P. Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Review. Published online: 21 Jan 2009. DOI:10.1002\/14651858.CD004105.."},{"key":"10.1016\/j.arbres.2012.04.001_bib0375","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.arbres.2009.10.008","article-title":"Utilidad de los macr\u00f3lidos como antiinflamatorios en las enfermedades respiratorias","volume":"46","author":"Sevilla-S\u00e1nchez","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0380","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/COPD.S23655","article-title":"Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations","volume":"6","author":"Pomares","year":"2011","journal-title":"Int J Chron Obst Respir Dis"},{"key":"10.1016\/j.arbres.2012.04.001_bib0385","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0390","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0395","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1183\/09031936.00195608","article-title":"Efficacy of moxifloxacin in the treatment of bronchial colonization in COPD","volume":"34","author":"Miravitlles","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0400","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","article-title":"Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial","volume":"11","author":"Sethi","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2012.04.001_bib0405","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1157\/13128330","article-title":"Diagn\u00f3stico y tratamiento de las bronquiectasias","volume":"44","author":"Vendrell","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.04.001_bib0410","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.rmed.2009.05.018","article-title":"Evaluation of withdrawal of maintenance tiotropium in COPD","volume":"103","author":"Adams","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0415","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.200206-512OC","article-title":"Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. The COPE study","volume":"166","author":"Van der Valk","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.04.001_bib0420","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1465-9921-12-107","article-title":"Withdrawal of inhaled corticosteroids in individuals with COPD \u2014 a systematic review and comment on trial methodology","volume":"12","author":"Nighat","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2012.04.001_bib0425","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pcrj.2003.11.005","article-title":"Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice","volume":"13","author":"Schermer","year":"2004","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.arbres.2012.04.001_bib0430","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.rmed.2011.07.002","article-title":"Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD","volume":"105","author":"Liesker","year":"2011","journal-title":"Respir Med"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289612001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289612001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T20:26:27Z","timestamp":1542918387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289612001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":86,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0300289612001159"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2012.04.001","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}